01530.HK
3SBio Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 15.75
−1.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 13.35x
- P/E 2027E
- 12.55x
- P/E 2028E
- 10.80x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.06x
- PEG TTM
- 0.07x
- Price / book
- 1.19x
- Price / sales
- 1.83x
- Price / cash flow
- 3.38x
Enterprise value
- Enterprise value
- HKD 22.2B
- EV / sales
- 1.06x
- EV / EBITDA
- 1.66x
- EV / EBIT
- 1.74x
- Market cap
- HKD 38.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026